Jason Kidd is a Nephrology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 98 publications with 1,479 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1250 E Marshall St
Internal Medicine
Richmond, VA 232985051
Telephone
804-828-9682Registry record last updated 2 Mar 2017.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year202521 payments
- Amgen Inc.Program year20242 payments
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.3%Calcium channel blocker13.4%Amlodipine Besylate63%Nifedipine Er30%Felodipine Er7%Part D<11 patientsAngiotensin receptor blocker (ARB)9.3%Losartan Potassium100%Part D≥47 patients+ 12 more classes in this area
Metabolism & gastrointestinal
16%SGLT2 inhibitor5.2%Farxiga61%Jardiance40%Part D≥14 patientsPotassium supplement3.7%Potassium Chloride100%Part D≥14 patients+ 3 more classes in this area
Other
8.7%Phosphate Binder5.7%Sevelamer Carbonate100%Part D≥29 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia3.1%Velphoro71%Lanthanum Carbonate29%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Acute effects of passive heat exposure on vascular function and exercise capacity in patients with chronic kidney disease
American Journal of Physiology-Heart and Circulatory Physiology
2026 - Acid ceramidase as a novel target for adiponectin receptor agonist to abrogate podocyte NLRP3 inflammasome activation and glomerular inflammation during obesity
Journal of Pharmacology and Experimental Therapeutics
2025 - Disrupted rest-activity circadian rhythms are associated with all-cause mortality in patients with chronic kidney diseases
Chronobiology International
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Jasmohan Bajaj, MD
Virginia Commonwealth University
Velimir Luketic, MD
Virginia Commonwealth University
Patrick Ching, MD, MPH
Virginia Commonwealth University
Robert Delorenzo, MD
Virginia Commonwealth University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”